Quick Answer
NUTRA PHARMA CORP reported Stockholders Equity of -$14.81 million for fiscal year 2024.
NUTRA PHARMA CORP Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2024 | -$14.81M | -7.6% |
| 2023 | -$13.77M | -11.2% |
| 2022 | -$12.38M | +40.7% |
| 2021 | -$20.88M | -81.6% |
| 2020 | -$11.49M | +1.8% |
| 2019 | -$11.70M | -97.1% |
| 2018 | -$5.94M | -9.7% |
| 2017 | -$5.41M | -20.8% |
| 2016 | -$4.48M | -25.2% |
| 2015 | -$3.57M | +0.6% |
| 2014 | -$3.59M | +14.8% |
| 2013 | -$4.22M | -18.0% |
| 2012 | -$3.58M | +8.6% |
| 2011 | -$3.91M | -69.0% |
| 2010 | -$2.31M | -102.2% |
| 2009 | -$1.14M | +55.2% |
| 2008 | -$2.56M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| June 30, 2025 | -$15.83M | -8.8% | +2.3% |
| March 31, 2025 | -$16.21M | -14.2% | -9.5% |
| December 31, 2024 | -$14.81M | -7.6% | +0.1% |
| September 30, 2024 | -$14.82M | -9.6% | -1.8% |
| June 30, 2024 | -$14.56M | -9.9% | -2.6% |
| March 31, 2024 | -$14.19M | -9.4% | -3.1% |
| December 31, 2023 | -$13.77M | -11.2% | -1.8% |
| September 30, 2023 | -$13.53M | +13.4% | -2.1% |
- NUTRA PHARMA CORP showed a decrease of -7.6% in Stockholders Equity compared to the prior fiscal year.
- Over the 2008–2024 period, NUTRA PHARMA CORP’s stockholders equity has declined by 479.3% (from -$2.56 million to -$14.81 million).
- The most recent figure is from NUTRA PHARMA CORP’s fiscal year 2024 report (Form 10-K), filed with the SEC on February 17, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: